Clinical trial
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
NCT00177814 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177814 |
|---|---|
| Title | Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit |
| Official title | Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Gram-negative Bacterial Infections |
| Enrollment | 1,000 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2017 |
| Completion | Jun 1, 2017 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: